Search

Displaying results 2141 - 2150 of 10000 in total
  1. Drug

    5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE

    go.drugbank.com/drugs/DB07787
    Experimental

    Synonyms: 5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE
  2. Drug

    [4-(4-Hydroxy-Benzyl)-2-(2-Hydroxy-1-Methyl-Ethyl)-5-Oxo-Imidazolidin-1-Yl]-Acetic Acid

    go.drugbank.com/drugs/DB03537
    Experimental

    Synonyms: [4-(4-Hydroxy-Benzyl)-2-(2-Hydroxy-1-Methyl-Ethyl)-5-Oxo-Imidazolidin-1-Yl]-Acetic Acid
  3. Drug

    4-Morpholin-4-Yl-Piperidine-1-Carboxylic Acid [1-(3-Benzenesulfonyl-1-Propyl-Allylcarbamoyl)-2-Phenylethyl]-Amide

    go.drugbank.com/drugs/DB02243
    Experimental

    Synonyms: 4-Morpholin-4-Yl-Piperidine-1-Carboxylic Acid [1-(3-Benzenesulfonyl-1-Propyl-Allylcarbamoyl)-2-Phenylethyl]-Amide
  4. Drug

    4-butyl-5-propyl-1,3-selenazol-2-amine

    go.drugbank.com/drugs/DB01740
    Experimental

    Synonyms: 2-amino-4-butyl-5-propylselenazole, 4-butyl-5-propyl-1,3-selenazol-2-amine
  5. Drug

    Annamycin

    go.drugbank.com/drugs/DB06420
    Investigational

    Synonyms: 2'-Iodo-3'-hydroxy-4'-epi-4-demethoxydoxorubicinCategories: P-glycoprotein inhibitors
  6. Drug

    beta-D-galactopyranosyl-(1->4)-beta-D-galactopyranose

    go.drugbank.com/drugs/DB02743
    Experimental

    Synonyms: β-D-Galp-(1→4)-β-D-Galp, 4-O-β-D-galactopyranosyl-β-D-galactopyranose
  7. Drug

    p-Heptylphenol

    go.drugbank.com/drugs/DB03941
    Experimental

    Synonyms: 4-n-Heptylphenol, 4-Heptylphenol
  8. Drug

    TT-232

    go.drugbank.com/drugs/DB12088
    Investigational

    Tln 232 is under investigation in clinical trial NCT00422786 (Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma).

    Salts: D-Phe-Cys-Tyr-D-Trp-Lys-Cys-Thr-NH2 (disulfide bridge: 2-6) acetateSynonyms: D-Phe-Cys-Tyr-D-Trp-Lys-Cys-Thr-NH2 (disulfide bridge: 2-6)
  9. Drug

    Bexotegrast

    go.drugbank.com/drugs/DB16515
    Investigational

    PLN-74809 is a small-molecule that dually inhibits both α<sub>v</sub>β<sub>6</sub> and α<sub>v</sub>β<sub>1</sub> to treat both idiopathic pulmonary fibrosis (IPF) and primary sclerosing cholangitis (PSC … The compound was granted orphan drug designation by the US FDA in August 2018 for treatment of IPF, and Pliant Therapeutics recently raised $100 million in Series C financing to support further clinical

    Synonyms: (2S)-4-(2-METHOXYETHYL-(4-(5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDIN-2-YL)BUTYL)AMINO)-2-(QUINAZOLIN-4-YLAMINO)BUTANOIC ACID, (S)-4-[(2-Methoxyethyl)[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]amino]-2-[(quinazolin-4-yl)amino]butanoic acid
  10. Drug

    DSM-265

    go.drugbank.com/drugs/DB12397
    Investigational

    DSM265 has been used in trials studying the prevention and treatment of Malaria.

    Categories: Heterocyclic Compounds, 1-RingSynonyms: Sulfur, (4-((2-(1,1-difluoroethyl)-5-methyl(1,2,4)triazolo(1,5-a)pyrimidin-7-yl)amino)phenyl)pentafluoro-, (oc-6-21)-, 2-(1,1-difluoroethyl)-5-methyl-N-[4-(pentafluoro-lambda6-sulfanyl)phenyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine